| Yazarlar (8) |
|
T.C. Sağlık Bakanlığı, Türkiye |
|
Kastamonu Üniversitesi, Türkiye |
Doç. Dr. Veysel Garani SOYLU
Kastamonu Üniversitesi, Türkiye |
Doç. Dr. Öztürk TAŞKIN
Kastamonu Üniversitesi, Türkiye |
Doç. Dr. Ufuk DEMİR
Kastamonu Üniversitesi, Türkiye |
|
Zonguldak Bülent Ecevit Üniversitesi, Türkiye |
Dr. Öğr. Üyesi Büşra TANYILDIZI KÜÇÜK
Kastamonu Üniversitesi, Türkiye |
Prof. Dr. Zahide DOĞANAY
Kastamonu Üniversitesi, Türkiye |
| Özet |
| BackgroundThis study by aiming to investigate the relationship of serum creatinine/alanine transaminase ratio (sCr/Alt) with mortality of patients aged 85 and over treated for acute ischemic strokeMethodsMedical records of patients aged 85 and over treated for acute ischemic stroke between January-2017 and October-2021 were evaluated. A total of 189 patients over the age of 85 with a diagnosis of cerebrovascular disease were included in the study.ResultsWhen we evaluated the 28-day mortality prediction performance of the variables, ALT (p< 0.001), serum creatinine (p< 0.001), serum creatinine/alanine transaminase (p< 0.001) were significantly higher in the mortal cases than in the other patients. We evaluated the 28-day mortality prediction performances of the variables, the sCr/Alt ratio was found to have 85.4% sensitivity and 84.8% specificity.ConclusionsCr/Alt value is a more valuable marker compared to NIHSS, APACHE II and SAPS II values which are mortality markers in advanced elderly patients with acute ischemic stroke in intensive care. |
| Anahtar Kelimeler |
| Makale Türü |
|
| Makale Alt Türü | Ulusal alan endekslerinde (TR Dizin, ULAKBİM) yayınlanan tam makale |
| Dergi Adı | Kastamonu Medical Journal |
| Dergi ISSN | 2757-9336 |
| Dergi Tarandığı Indeksler | TR DİZİN |
| Makale Dili | Türkçe |
| Basım Tarihi | 06-2025 |
| Cilt No | 5 |
| Doi Numarası | 10.51271/KMJ-0196 |
| Makale Linki | https://doi.org/10.51271/kmj-0196 |